Dr Harald Nusser
Dr Nusser is Head of Global Patient Solutions at Gilead Sciences, a position he has held since May 2021. Previously, Dr. Nusser was the Global Head of Novartis Social Business and has been leading Novartis Access since June 2015. Since October 2016, he has also taken on the responsibility for the Novartis Malaria Initiative, the Novartis Healthy Family programmes and SMS for Life, which have been combined with Novartis Access into a newly formed unit called Novartis Social Business. Prior to this position, he worked as Head of Portfolio Management for Bayer in 2006, where he managed the Holistic R&D Portfolio Review for Bayer Pharma and the annual Strategic Planning Process for Bayer HealthCare, led restructuring activities and became Managing Director for Bayer spol. s r.o. in Slovakia in 2010. Starting in 2012, he led the Bayer HealthCare business (comprising Animal Health, Radiology, Diabetes Care, OTC and Pharmaceuticals).
